Paul H. Sugarbaker M.D.
- Director of Surgical Oncology
- Washington Cancer Institute
Dr. Paul Sugarbaker serves as the director of surgical oncology at the Washington Cancer Institute in Washington, DC. He is considered to be among the world’s leading specialists in the treatment of peritoneal mesothelioma with a multi-disciplinary approach that represents the forefront of treatment technology for cancer of this variety.
Dr. Sugarbaker attended Wheaton College, earning a bachelor’s of science degree in 1963. He then enrolled at Cornell University Medical College, where he earned his medical degree with honors distinctions in 1967. He completed his residency in general surgery in at Peter Bent-Brigham Hospital in Boston in 1973. His surgical fellowship was completed at Massachusetts General Hospital in Boston in 1976. While in Boston, he received his masters of immunology from Harvard University in 1983.
Dr. Sugarbaker has published nearly 700 articles, books, and reports detailing his advanced multi-modal approaches to the treatment of mesothelioma and other cancers. His most notable work though, has been among patients diagnosed with malignant peritoneal mesothelioma, which occurs in the lining of the abdominal cavity. Dr. Sugarbaker’s multi-modal approach utilizes cyto-reductive surgery, during which a chemical agent is applied to the affected tissue in a procedure known as intraperitoneal chemotherapy. Systemic chemotherapy is then administered on a specific timeline outlined prior to surgery to maximize the efficacy of the dosage. Several of Sugarbaker’s peers are now utilizing similar multi-disciplinary treatment regimens in their approach to other cancers as a result of the initial success of Sugarbaker’s program.
- Washington Cancer Institute. Physician Profile.
Last modified: December 24, 2010.